ADMA
Adma Biologics Inc. (ADMA)
NASDAQ · Healthcare
Adma Biologics Inc. annual/quarterly total liabilities history from 2011 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Adma Biologics Inc. total liabilities for the quarter ending December 31, 2025 were 146.9M, a 5.20% increase year-over-year.
- Adma Biologics Inc. total liabilities for 2025 were 146.9M, a 5.20% increase from 2024.
- Adma Biologics Inc. total liabilities for 2024 were 139.7M, a 28.00% decrease from 2023.
- Adma Biologics Inc. total liabilities for 2023 were 194.0M, a 1.28% decrease from 2022.
- Adma Biologics Inc. total liabilities for 2022 were 196.5M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Adma Biologics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $147 |
| 2024 | $140 |
| 2023 | $194 |
| 2022 | $196 |
| 2021 | $135 |
| 2020 | $119 |
| 2019 | $101 |
| 2018 | $69 |
| 2017 | $68 |
| 2016 | $28 |
| 2015 | $23 |
| 2014 | $21 |
| 2013 | $10 |
| 2012 | $6 |
| 2011 | $3 |
| Adma Biologics Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $147 |
| 2024-12-31 | $140 |
| 2023-12-31 | $194 |
| 2022-12-31 | $196 |
| 2021-12-31 | $135 |
| 2020-12-31 | $119 |
| 2019-12-31 | $101 |
| 2018-12-31 | $69 |
| 2017-12-31 | $68 |
| 2016-12-31 | $28 |
| 2015-12-31 | $23 |
| 2014-12-31 | $21 |
| 2013-12-31 | $10 |
| 2012-12-31 | $6 |
| 2011-12-31 | $3 |
Adma Biologics Inc. Total Liabilities — FAQ
Adma Biologics Inc. (ADMA) total liabilities over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ADMA's total liabilities history?
The chart and table above show Adma Biologics Inc.'s total liabilities by year and by quarter, including the growth rate.